Loading…
Loading…
Evaluation of CYP1A2 activity: Relationship between the endogenous urinary 6‐hydroxymelatonin to melatonin ratio and paraxanthine to caffeine ratio in dried blood spots
Magliocco, Gaëlle, Desmeules, Jules, Samer, Caroline Flora, Thomas, Aurélien, Daali, Youssef
Published in Clinical and translational science (01.06.2022)
Published in Clinical and translational science (01.06.2022)
Get full text
Journal Article
Loading…
Loading…
Loading…
Loading…
PCB Exposure and in Vivo CYP1A2 Activity among Native Americans
Fitzgerald, Edward F., Hwang, Syni-An, Lambert, George, Gomez, Marta, Tarbell, Alice
Published in Environmental health perspectives (01.03.2005)
Published in Environmental health perspectives (01.03.2005)
Get full text
Journal Article
Loading…
Low CYP1A2 activity associated with testicular cancer
Vistisen, Kirsten, Loft, Steffen, Olsen, Jørgen H., Vallentin, Susanne, Ottesen, Svend, Hirsch, Fred R., Poulsen, Henrik E.
Published in Carcinogenesis (New York) (01.06.2004)
Published in Carcinogenesis (New York) (01.06.2004)
Get full text
Journal Article
Loading…
Loading…
Loading…
Clozapine disposition covaries with CYP1A2 activity determined by a caffeine test
Bertilsson, L, Carrillo, JA, Dahl, ML, Llerena, A, Alm, C, Bondesson, U, Lindstrom, L, Rodriguez de la Rubia, I, Ramos, S, Benitez, J
Published in BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (01.11.1994)
Published in BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (01.11.1994)
Get full text
Journal Article
Publication
Loading…
Effect of daidzein on CYP1A2 activity and pharmacokinetics of theophylline in healthy volunteers
Peng, Wen-Xing, Li, Huan-De, Zhou, Hong-Hao
Published in European journal of clinical pharmacology (01.07.2003)
Published in European journal of clinical pharmacology (01.07.2003)
Get full text
Journal Article
Loading…
Parkinson's disease and CYP1A2 activity
Forsyth, J. T., Grünewald, R. A., Rostami‐Hodjegan, A., Lennard, M. S., Sagar, H. J., Tucker, G. T.
Published in British journal of clinical pharmacology (01.10.2000)
Published in British journal of clinical pharmacology (01.10.2000)
Get full text
Journal Article
Loading…
In vivo inhibition of human CYP1A2 activity by oltipraz
Sofowora, Gbemiga, Choo, Edna, Mayo, Gail, Shyr, Yu, Wilkinson, Grant
Published in Cancer chemotherapy and pharmacology (01.06.2001)
Published in Cancer chemotherapy and pharmacology (01.06.2001)
Get full text
Journal Article
Loading…
Loading…
Loading…
CYP1A2 activity, gender and smoking, as variables influencing the toxicity of caffeine
CARRILLO, JUAN A., BENITEZ, JULIO
Published in British journal of clinical pharmacology (01.06.1996)
Published in British journal of clinical pharmacology (01.06.1996)
Get full text
Journal Article
Loading…
Loading…
Lower levels of urinary 2-amino-3,8-dimethylimidazo[4,5-f]-quinoxaline (MeIQx) in humans with higher CYP1A2 activity
Sinha, R, Rothman, N, Mark, S D, Murray, S, Brown, E D, Levander, O A, Davies, D S, Lang, N P, Kadlubar, F F, Hoover, R N
Published in Carcinogenesis (New York) (01.11.1995)
Published in Carcinogenesis (New York) (01.11.1995)
Get more information
Journal Article
Loading…
Influence of the urine flow rate on some caffeine metabolite ratios used to assess CYP1A2 activity
Sinués, Blanca, Fanlo, Ana, Bernal, María Luisa, Mayayo, Esteban, Soriano, María Antonia, Martínez-Ballarin, Enrique
Published in Therapeutic drug monitoring (01.12.2002)
Published in Therapeutic drug monitoring (01.12.2002)
Get more information
Journal Article
Loading…
Determination of urinary 13C-caffeine metabolites by liquid chromatography–mass spectrometry: the use of metabolic ratios to assess CYP1A2 activity
Caubet, Marie-Sophie, Comte, Blandine, Brazier, Jean-Louis
Published in Journal of pharmaceutical and biomedical analysis (01.02.2004)
Published in Journal of pharmaceutical and biomedical analysis (01.02.2004)
Get full text
Journal Article